Combination therapy in multiple sclerosis : The Lancet Neurology
Links shared publicly online about this topic.
- 1,355total visits
Combination therapy in multiple sclerosis : The Lancet Neurology
View full resource at thelancet.com
Tags: Neurology, Multiple Sclerosis
Most Recently Shared on February 26, 2010 at 12:23 am By:
Combination therapies in multiple sclerosis - http://bit.ly/9aBmLv
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial : The Lancet Neurology
thelancet.com — “Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. By - Prof Per Soelberg Sorensen MD, ...” View full resource at thelancet.com
Most Recently Shared on July 27, 2011 at 11:02 pm By:
Edgar Avalos, MD Neurology and Health Group
No beneficial effect of simvastatin as add-on therapy to interferon beta-1a http://t.co/Uk7KtUc
Neurology Article | Multiple Sclerosis
mdlinx.com — “Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial : The Lancet Neurology” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 6:23 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN... http://bit.ly/r6OKbK #neuro
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial : The Lancet Neurology
thelancet.com — “Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. By - Prof Per Soelberg Sorensen MD, ...” View full resource at thelancet.com
Most Recently Shared on July 11, 2011 at 5:00 am By:
Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective. We aimed to .... http://bit.ly/mUbJIn
Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria : The Lancet Neurology
thelancet.com — “Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria. By - Hans-Peter Hartung, Orhan Aktas” View full resource at thelancet.com
Most Recently Shared on March 23, 2011 at 2:28 am By:
[Comment] Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy cri... http://bit.ly/fCvyi5
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial : The Lancet Neurology
thelancet.com — “Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group tr...” View full resource at thelancet.com
Most Recently Shared on June 8, 2010 at 5:44 pm By:
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN stu... http://bit.ly/awrkry
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial : The Lancet Neurology
thelancet.com — “Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group tr...” View full resource at thelancet.com
Most Recently Shared on June 8, 2010 at 1:03 pm By:
MECOMBIN study published in The Lancet Neurology http://bit.ly/axFJ6W
Internal Med Medical News about Multiple Sclerosis
mdlinx.com — “Combination therapy in multiple sclerosis” View full resource at mdlinx.com
Most Recently Shared on February 17, 2010 at 10:15 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Int Med: Combination therapy in multiple sclerosis: The Lancet Neurology http://url4.eu/1QDXU
Neurology Medical News about Multiple Sclerosis
mdlinx.com — “Combination therapy in multiple sclerosis” View full resource at mdlinx.com
Most Recently Shared on February 17, 2010 at 9:08 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: Combination therapy in multiple sclerosis: The Lancet Neurology http://bit.ly/aiQXgr
Promising therapy for relapsing multibple sclerosis
eurekalert.org — “An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis. This new study was published online Feb. 16, 2010, and in the March edition of the Lancet Neurology.” View full resource at eurekalert.org
Most Recently Shared on February 16, 2010 at 8:08 pm By:
Stephen Roberts, MD Physician and Doctor
Breaking News! Promising therapy for relapsing multiple sclerosis - published today! http://bit.ly/bmS2uj
Neurology Medical News about Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting
mdlinx.com — “A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing"remitting multiple sclerosis (TIME MS)” View full resource at mdlinx.com
Most Recently Shared on January 5, 2010 at 9:54 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combin http://url4.eu/13ckw
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial : The Lancet Neurology
thelancet.com — “NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. By -...” View full resource at thelancet.com
Most Recently Shared on May 12, 2009 at 1:15 pm By:
[Lancet Neurology] [Articles] NORdic trial of oral Methylprednisolone as add-on therapy to Int.. http://tinyurl.com/qqnez5
Stem-cell therapy reduces symptoms of multiple sclerosis | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “Infusing multiple sclerosis patients with their own immune stem cells appears to help the immune system "reset" itself and fight off the disease, according to a study that will be published online Friday in the Lancet Neurology. The study, an...” View full resource at latimesblogs.latimes.com
Most Recently Shared on January 29, 2009 at 11:39 pm By:
LA Times Health News Health News
Stem-cell therapy reduces symptoms of multiple sclerosis: Infusing multiple sclerosis patients with their own im.. http://tinyurl.com/blx93o
Advertisement
